SCHEMBL5705354

SCHEMBL5705354

CCC(C)(C)CCC(=O)CCC(=O)CCC(C)(C)CC

nearest known ligand 0.32

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
THRB P10828 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
FFAR1 O14842 1/20 0.31
CPT2 P23786 1/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11564017 0.97 TDP1 (0.33) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL8897573 0.90 CES2 (0.38) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL27511799 0.87 TDP1 (0.43) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL23380020 0.86
SCHEMBL7025017 0.85
SCHEMBL8897417 0.83 KMT2A (0.55) ALDH1A1KMT2AMEN1TDP1FFAR1
SCHEMBL8743404 0.82
SCHEMBL8743263 0.81 S1PR1 (0.32)
SCHEMBL1785746 0.79 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL20490036 0.79 ALDH1A1 (0.32) ALDH1A1KMT2AMEN1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP claimed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed
EP-1701931-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics, Inc. (US) 2006-09-20 EP disclosed
WO-2005068412-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed